The dispute involved payments made by Ranbaxy, now merged with Sun Pharmaceutical Industries Ltd, to Teva Israel under a 2011 settlement relating to the US launch of generic atorvastatin.
Delhi High Court says payments to overseas units aren’t automatically taxable in India